Fed. Circ. Backs AstraZeneca, Impax Win In Zomig Patent Suit
The Federal Circuit on Thursday affirmed a Delaware federal court ruling that rejected arguments made by generic-drug maker Lannett Co. Inc. that two AstraZeneca AB nasal spray patents covering Impax's migraine...To view the full article, register now.
Already a subscriber? Click here to view full article